AccuGenomics, Inc.
AccuGenomics manufactures innovative multiplexed spike-in QC standards (SNAQ-SEQ) that enable a host of highly sensitive next generation sequencing applications. SNAQ-SEQ internal standards improve the accuracy and performance of NGS-based assays. SNAQ-SEQ is based on technology exclusively licensed to AccuGenomics from the University of Toledo.Our corporate headquarters includes over 5000 sf of development and manufacturing suites and are located in Wilmington, NC.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical / Health Care
- Market Focus:
- Nationally (across the country)
Mission
AccuGenomics is driven to improve the accuracy and performance of clinical sequencing for better patient outcomes. The rapid pace of innovation in sequencing-based diagnostics continues to push the limits of detectability for low abundance biomarkers, increasing the need to demonstrate the analytical performance of these tests for patients and healthcare providers. AccuGenomics is actively developing technology solutions that enable test developers and implementers to demonstrate the highest performance levels of their assay.
AccuGenomics improves the diagnostic accuracy and confidence in today’s next generation precision medicine assays through the use of their exclusively-licensed SNAQ™-SEQ internal standards technology. SNAQ-SEQ enables a host of high-sensitive NGS applications including improved ctDNA detection of rare variants; rapid adventitious agent detection in cell therapy manufacturing including CAR-T cells and genetically-engineered stem cells.